67/100BAmgen reports its Q4 FY2026 results on 2 February 2027, after the market closes. Analysts expect earnings per share of 5.64 USD and revenue of 10.45B USD.
In Q3 FY2026, reported on 3 November 2026, Amgen earned 6.45 USD a share against the 5.79 USD analysts expected (+11.4%), on revenue of 10.37B USD against 10.07B USD (+3.0%).
| Period | Report date | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth | Next-day move |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 FY2028 | 6.28 | — | — | +9.91% | 10.03B | — | — | +4.90% | — | |
| Q4 FY2027 | 6.35 | — | — | +12.57% | 10.76B | — | — | +2.91% | — | |
| Q1 FY2027 | 5.71 | — | — | +10.92% | 9.56B | — | — | +10.94% | — | |
| Q4 FY2026 | 5.64 | — | — | +6.62% | 10.45B | — | — | +5.97% | — | |
| Q3 FY2026 | 5.79 | 6.45 | +11.40% | +14.36% | 10.07B | 10.37B | +2.95% | +8.45% | +3.8% | |
| Q2 FY2026 | 5.62 | 6.29 | +11.92% | +4.49% | 9.43B | 10.05B | +6.66% | +9.68% | +4.5% | |
| Q1 FY2026 | 4.77 | 5.15 | +7.97% | +5.10% | 8.58B | 8.62B | +0.50% | +5.76% | -4.8% | |
| Q4 FY2025 | 4.73 | 5.29 | +11.84% | -0.38% | 9.47B | 9.87B | +4.14% | +8.58% | +8.1% | |
| Q3 FY2025 | 5.02 | 5.64 | +12.35% | +1.08% | 8.97B | 9.56B | +6.59% | +12.40% | +7.8% | |
| Q2 FY2025 | 5.28 | 6.02 | +14.02% | +21.13% | 8.94B | 9.17B | +2.59% | +9.29% | -5.2% | |
| Q1 FY2025 | 4.27 | 4.90 | +14.75% | +23.74% | 8.06B | 8.15B | +1.14% | +9.43% | -0.8% | |
| Q4 FY2024 | 5.04 | 5.31 | +5.36% | +12.74% | 8.88B | 9.09B | +2.31% | +10.86% | +6.5% | |
| Q3 FY2024 | 5.11 | 5.58 | +9.20% | +12.50% | 8.50B | 8.50B | +0.06% | +23.18% | +1.3% | |
| Q2 FY2024 | 4.98 | 4.97 | -0.20% | -0.60% | 8.35B | 8.39B | +0.43% | +20.07% | -5.0% | |
| Q1 FY2024 | 3.88 | 3.96 | +2.06% | -0.50% | 7.45B | 7.45B | -0.06% | +21.98% | +11.8% | |
| Q4 FY2023 | 4.59 | 4.71 | +2.61% | +15.16% | 8.13B | 8.20B | +0.86% | +19.84% | -6.5% | |
| Q3 FY2023 | 4.65 | 4.96 | +6.67% | +5.53% | 6.62B | 6.90B | +4.33% | +3.77% | -2.9% | |
| Q2 FY2023 | 4.44 | 5.00 | +12.61% | +7.53% | 6.68B | 6.99B | +4.64% | +5.94% | +5.4% | |
| Q1 FY2023 | 3.85 | 3.98 | +3.38% | -6.35% | 6.65B | 6.11B | -8.17% | -2.13% | -0.2% | |
| Q4 FY2022 | 4.04 | 4.09 | +1.24% | -6.19% | 6.74B | 6.84B | +1.41% | -0.10% | -2.5% | |
| Q3 FY2022 | 4.44 | 4.70 | +5.86% | +0.64% | 6.56B | 6.65B | +1.34% | -0.81% | +1.2% | |
| Q2 FY2022 | 4.40 | 4.65 | +5.68% | +6.16% | 6.53B | 6.59B | +0.96% | +1.04% | -0.3% | |
| Q1 FY2022 | 4.22 | 4.25 | +0.71% | +14.86% | 6.07B | 6.24B | +2.78% | +5.71% | +1.3% | |
| Q4 FY2021 | 4.14 | 4.36 | +5.31% | +14.44% | 6.87B | 6.85B | -0.34% | +3.20% | +7.8% | |
| Q3 FY2021 | 4.22 | 4.67 | +10.66% | +6.86% | 6.71B | 6.71B | -0.08% | +4.41% | +1.8% | |
| Q2 FY2021 | 4.13 | 4.38 | +6.05% | +3.06% | 6.45B | 6.53B | +1.18% | +5.16% | -6.5% | |
| Q1 FY2021 | 4.05 | 3.70 | -8.64% | -11.27% | 6.29B | 5.90B | -6.12% | -4.22% | -7.3% | |
| Q4 FY2020 | 3.36 | 3.81 | +13.39% | +4.67% | 5.81B | 6.63B | +14.14% | +7.05% | -1.3% | |
| Q3 FY2020 | 3.81 | 4.37 | +14.70% | +19.40% | 5.60B | 6.42B | +14.70% | +11.96% | +0.7% | |
| Q2 FY2020 | 3.81 | 4.25 | +11.55% | +7.05% | 5.59B | 6.21B | +10.97% | +5.71% | -2.6% | |
| Q1 FY2020 | 3.70 | 4.17 | +12.70% | +17.13% | 5.56B | 6.16B | +10.90% | +10.87% | -3.3% | |
| Q4 FY2019 | 3.47 | 3.64 | +4.90% | +6.43% | 5.91B | 6.20B | +4.90% | -0.53% | -4.5% | |
| Q3 FY2019 | 3.53 | 3.66 | +3.68% | -0.81% | 5.53B | 5.74B | +3.68% | -2.83% | +0.9% | |
| Q2 FY2019 | 3.59 | 3.97 | +10.58% | +3.66% | 5.31B | 5.87B | +10.58% | -3.10% | +5.7% | |
| Q1 FY2019 | 3.48 | 3.56 | +2.30% | +2.59% | 5.43B | 5.56B | +2.30% | +0.05% | -1.6% | |
| Q4 FY2018 | 3.27 | 3.42 | +4.59% | +18.34% | 5.96B | 6.23B | +4.59% | +7.38% | -3.7% | |
| Q3 FY2018 | 3.45 | 3.69 | +6.96% | +12.84% | 5.52B | 5.90B | +6.96% | +2.27% | +1.6% | |
| Q2 FY2018 | 3.54 | 3.83 | +8.19% | +17.13% | 5.60B | 6.06B | +8.19% | +4.29% | -0.8% | |
| Q1 FY2018 | 3.23 | 3.47 | +7.43% | +10.16% | 5.19B | 5.55B | +7.10% | +1.65% | +1.7% | |
| Q4 FY2017 | 3.04 | 2.89 | -4.93% | 0.00% | 6.08B | 5.80B | -4.62% | -2.73% | +0.8% | |
| Q3 FY2017 | 3.11 | 3.27 | +5.14% | +8.28% | 5.49B | 5.77B | +5.14% | -0.65% | -0.5% | |
| Q2 FY2017 | 3.11 | 3.27 | +5.14% | +15.14% | 5.53B | 5.81B | +5.14% | +2.14% | -2.8% | |
| Q1 FY2017 | 3.00 | 3.15 | +5.00% | +8.62% | 5.20B | 5.46B | +5.00% | -1.14% | -1.2% | |
| Q4 FY2016 | 2.79 | 2.89 | +3.58% | +10.73% | 5.76B | 5.97B | +3.58% | +7.75% | +5.0% | |
| Q3 FY2016 | 2.79 | 3.02 | +8.24% | +11.03% | 5.37B | 5.81B | +8.24% | +1.54% | -9.8% | |
| Q2 FY2016 | 2.74 | 2.84 | +3.65% | +10.51% | 5.49B | 5.69B | +3.65% | +5.92% | +0.4% | |
| Q1 FY2016 | 2.60 | 2.90 | +11.54% | +16.94% | 4.96B | 5.53B | +11.54% | +9.82% | -1.4% | |
| Q4 FY2015 | 2.29 | 2.61 | +13.97% | +20.83% | 4.86B | 5.54B | +13.97% | +3.85% | +3.0% | |
| Q3 FY2015 | 2.38 | 2.72 | +14.29% | +18.26% | 5.01B | 5.72B | +14.29% | +13.75% | -1.3% | |
| Q2 FY2015 | 2.43 | 2.57 | +5.76% | +8.44% | 5.08B | 5.37B | +5.76% | +3.67% | +2.9% | |
| Q1 FY2015 | 2.10 | 2.48 | +18.10% | +32.62% | 4.26B | 5.03B | +18.10% | +11.32% | +0.4% | |
| Q4 FY2014 | 2.05 | 2.16 | +5.37% | +18.68% | 5.06B | 5.33B | +5.37% | +6.39% | -2.7% | |
| Q3 FY2014 | 2.11 | 2.30 | +9.00% | +18.56% | 4.62B | 5.03B | +9.00% | +5.96% | +6.1% | |
| Q2 FY2014 | 2.07 | 2.37 | +14.49% | +25.40% | 4.52B | 5.18B | +14.49% | +10.71% | +5.4% | |
| Q1 FY2014 | 1.89 | 1.87 | -1.06% | -4.59% | 4.69B | 4.52B | -3.61% | +6.68% | -5.0% | |
| Q4 FY2013 | 1.67 | 1.82 | +8.98% | +30.00% | 4.63B | 5.01B | +8.33% | +13.35% | -1.3% | |
| Q3 FY2013 | 1.77 | 1.94 | +9.60% | +16.17% | 4.33B | 4.75B | +9.60% | +9.93% | -0.5% | |
| Q2 FY2013 | 1.74 | 1.89 | +8.62% | +3.28% | 4.31B | 4.68B | +8.62% | +4.51% | -2.6% | |
| Q1 FY2013 | 1.84 | 1.96 | +6.52% | +21.74% | 3.98B | 4.24B | +6.52% | +4.69% | -6.9% | |
| Q4 FY2012 | 1.44 | 1.40 | -2.78% | +15.70% | 4.36B | 4.42B | +1.45% | +11.28% | -0.5% | |
| Q3 FY2012 | 1.47 | 1.67 | +13.61% | +19.29% | 3.80B | 4.32B | +13.61% | +9.51% | +0.2% | |
| Q2 FY2012 | 1.54 | 1.83 | +18.83% | +33.58% | 3.77B | 4.48B | +18.83% | +13.08% | +5.8% | |
| Q1 FY2012 | 1.45 | 1.61 | +11.03% | +20.15% | 3.65B | 4.05B | +11.03% | +9.23% | +2.3% | |
| Q4 FY2011 | 1.22 | 1.21 | -0.82% | +3.42% | 4.01B | 3.97B | -0.82% | +3.44% | +0.4% | |
| Q3 FY2011 | 1.29 | 1.40 | +8.53% | +2.94% | 3.63B | 3.94B | +8.53% | +3.35% | -4.2% | |
| Q2 FY2011 | 1.28 | 1.37 | +7.03% | -0.72% | 3.70B | 3.96B | +7.03% | +4.07% | -1.7% | |
| Q1 FY2011 | 1.29 | 1.34 | +3.88% | +3.08% | 3.57B | 3.71B | +3.88% | +3.17% | -4.4% | |
| Q4 FY2010 | 1.11 | 1.17 | +5.41% | +11.43% | 3.64B | 3.84B | +5.41% | +0.84% | -0.2% | |
| Q3 FY2010 | 1.27 | 1.36 | +7.09% | -8.72% | 3.56B | 3.82B | +7.09% | +0.10% | -1.2% | |
| Q2 FY2010 | 1.30 | 1.38 | +6.15% | +6.98% | 3.58B | 3.80B | +6.15% | +2.45% | +2.2% | |
| Q1 FY2010 | 1.23 | 1.30 | +5.69% | +20.37% | 3.40B | 3.59B | +5.69% | +8.59% | -0.9% | |
| Q4 FY2009 | 1.12 | 1.05 | -6.25% | -0.94% | 4.05B | 3.81B | -5.88% | +1.55% | +1.6% | |
| Q3 FY2009 | 1.27 | 1.49 | +17.32% | +21.14% | 3.25B | 3.81B | +17.32% | -1.63% | -4.3% | |
| Q2 FY2009 | 1.16 | 1.29 | +11.21% | +13.16% | 3.34B | 3.71B | +11.21% | -1.35% | +2.7% | |
| Q1 FY2009 | 1.15 | 1.08 | -6.09% | -3.57% | 3.52B | 3.31B | -6.09% | -8.44% | +6.4% | |
| Q4 FY2008 | 1.07 | 1.06 | -0.93% | +6.00% | 3.79B | 3.75B | -0.93% | +0.16% | -2.4% | |
| Q3 FY2008 | 1.08 | 1.23 | +13.89% | +13.89% | 3.40B | 3.88B | +13.89% | +7.31% | +11.8% | |
| Q2 FY2008 | 1.02 | 1.14 | +11.76% | +1.79% | 3.37B | 3.76B | +11.76% | +0.97% | +3.0% | |
| Q1 FY2008 | 1.04 | 1.12 | +7.69% | +3.70% | 3.35B | 3.61B | +7.69% | -2.01% | -0.4% | |
| Q4 FY2007 | 0.97 | 1.00 | +3.09% | +11.11% | 3.63B | 3.75B | +3.09% | -2.35% | +4.4% | |
| Q3 FY2007 | 1.03 | 1.08 | +4.85% | +3.85% | 3.44B | 3.61B | +4.85% | -0.03% | -1.4% | |
| Q2 FY2007 | 1.06 | 1.12 | +5.66% | +6.67% | 3.53B | 3.73B | +5.66% | +3.44% | -1.0% | |
| Q1 FY2007 | 1.08 | 1.08 | 0.00% | +18.68% | 3.69B | 3.69B | 0.00% | +14.61% | -1.6% | |
| Q4 FY2006 | 0.95 | 0.90 | -5.26% | +20.00% | 4.05B | 3.84B | -5.26% | +17.24% | -4.5% | |
| Q3 FY2006 | 0.98 | 1.04 | +6.12% | +22.35% | 3.40B | 3.61B | +6.12% | +14.52% | +2.1% | |
| Q2 FY2006 | 0.94 | 1.05 | +11.70% | +19.32% | 3.23B | 3.60B | +11.70% | +13.62% | +3.5% | |
| Q1 FY2006 | 0.89 | 0.91 | +2.25% | +26.39% | 3.15B | 3.22B | +2.25% | +13.55% | -3.8% | |
| Q4 FY2005 | 0.76 | 0.75 | -1.32% | +29.31% | 3.31B | 3.27B | -1.30% | +12.44% | -0.8% | |
| Q3 FY2005 | 0.82 | 0.85 | +3.66% | +32.81% | 3.04B | 3.15B | +3.66% | +16.26% | -5.1% | |
| Q2 FY2005 | 0.72 | 0.88 | +22.22% | +41.94% | 2.60B | 3.17B | +22.22% | +22.71% | +15.1% | |
| Q1 FY2005 | 0.67 | 0.72 | +7.46% | +26.32% | 2.64B | 2.83B | +7.46% | +20.91% | -0.6% | |
| Q4 FY2004 | 0.61 | 0.58 | -4.92% | +26.09% | 3.05B | 2.91B | -4.69% | +23.98% | -0.5% | |
| Q3 FY2004 | 0.62 | 0.64 | +3.23% | +20.75% | 2.63B | 2.71B | +3.23% | +22.90% | -3.8% | |
| Q2 FY2004 | 0.60 | 0.62 | +3.33% | +26.53% | 2.50B | 2.58B | +3.33% | +26.64% | -1.3% | |
| Q1 FY2004 | 0.55 | 0.57 | +3.64% | +35.71% | 2.26B | 2.34B | +3.64% | +33.03% | +2.0% | |
| Q4 FY2003 | 0.48 | 0.46 | -4.17% | +31.43% | 2.44B | 2.35B | -4.00% | +32.85% | +4.0% | |
| Q3 FY2003 | 0.51 | 0.53 | +3.92% | +55.88% | 2.12B | 2.21B | +3.92% | +47.23% | -5.3% | |
| Q2 FY2003 | 0.46 | 0.49 | +6.52% | +28.95% | 1.92B | 2.04B | +6.52% | +74.59% | +1.1% | |
| Q1 FY2003 | 0.39 | 0.42 | +7.69% | +31.25% | 1.64B | 1.76B | +7.69% | +74.64% | +4.7% | |
| Q4 FY2002 | 0.35 | 0.35 | 0.00% | +16.67% | 1.77B | 1.77B | 0.00% | +57.08% | -2.4% | |
| Q3 FY2002 | 0.32 | 0.34 | +6.25% | +13.33% | 1.41B | 1.50B | +6.25% | +49.47% | -2.6% | |
| Q2 FY2002 | 0.35 | 0.38 | +8.57% | +26.67% | 1.15B | 1.17B | +1.62% | +18.49% | +13.1% | |
| Q1 FY2002 | 0.32 | 0.32 | 0.00% | +14.29% | 1.01B | 1.01B | 0.00% | +11.86% | -2.5% | |
| Q4 FY2001 | 0.31 | 0.30 | -3.23% | +25.00% | 1.16B | 1.12B | -3.23% | +24.12% | -2.1% | |
| Q3 FY2001 | 0.29 | 0.30 | +3.45% | +3.45% | 969.66M | 1.00B | +3.45% | +11.10% | +2.1% | |
| Q2 FY2001 | 0.28 | 0.30 | +7.14% | +7.14% | 920.92M | 986.70M | +7.14% | +13.69% | +5.4% | |
| Q1 FY2001 | 0.27 | 0.28 | +3.70% | +12.00% | 869.40M | 901.60M | +3.70% | +16.82% | +7.1% | |
| Q4 FY2000 | 0.25 | 0.24 | -4.00% | -7.69% | 942.03M | 905.80M | -3.85% | +1.87% | +4.3% | |
| Q3 FY2000 | 0.27 | 0.29 | +7.41% | +3.57% | 884.02M | 902.90M | +2.14% | +11.09% | -13.4% | |
| Q2 FY2000 | 0.27 | 0.28 | +3.70% | +12.00% | 881.74M | 867.90M | -1.57% | +10.29% | -1.3% | |
| Q1 FY2000 | 0.25 | 0.25 | 0.00% | +8.70% | 814.10M | 771.80M | -5.20% | +7.90% | +5.4% | |
| Q4 FY1999 | 0.25 | 0.26 | +4.00% | +13.04% | 853.63M | 889.20M | +4.17% | +21.54% | -7.6% | |
| Q3 FY1999 | 0.24 | 0.28 | +16.67% | +33.33% | 726.17M | 812.80M | +11.93% | +19.49% | -7.0% | |
| Q2 FY1999 | 0.23 | 0.25 | +8.70% | +19.05% | 754.86M | 786.90M | +4.24% | +22.74% | +9.0% | |
| Q1 FY1999 | 0.22 | 0.23 | +4.55% | +27.78% | 713.09M | 715.30M | +0.31% | +21.36% | -7.2% | |
| Q4 FY1998 | 0.21 | 0.23 | +9.52% | +35.29% | 661.92M | 731.60M | +10.53% | +23.58% | +6.9% | |
| Q3 FY1998 | 0.20 | 0.21 | +5.00% | +23.53% | 667.52M | 680.20M | +1.90% | +16.55% | -0.5% | |
| Q2 FY1998 | 0.18 | 0.21 | +16.67% | +16.67% | 563.06M | 641.10M | +13.86% | +5.67% | +6.7% | |
| Q1 FY1998 | 0.17 | 0.18 | +5.88% | +12.50% | 571.77M | 589.40M | +3.08% | +4.61% | +0.7% | |
| Q4 FY1997 | 0.17 | 0.17 | 0.00% | +6.25% | 592.00M | 592.00M | 0.00% | +1.70% | +3.0% | |
| Q3 FY1997 | 0.17 | 0.17 | 0.00% | +6.25% | 598.30M | 583.60M | -2.46% | +4.89% | +4.5% | |
| Q2 FY1997 | 0.18 | 0.18 | 0.00% | +12.50% | 620.50M | 606.70M | -2.22% | +8.17% | +4.8% | |
| Q1 FY1997 | 0.16 | 0.16 | 0.00% | +23.08% | 575.50M | 563.40M | -2.10% | +12.97% | -2.1% | |
| Q4 FY1996 | 0.16 | 0.16 | 0.00% | +14.29% | 582.10M | 582.10M | 0.00% | +15.43% | +2.3% | |
| Q3 FY1996 | 0.15 | 0.16 | +6.67% | +23.08% | — | 556.40M | — | +14.86% | -1.9% | |
| Q2 FY1996 | 0.15 | 0.16 | +6.67% | +33.33% | — | 560.90M | — | +15.86% | +1.6% | |
| Q1 FY1996 | 0.13 | 0.13 | 0.00% | +30.00% | — | 498.70M | — | +15.71% | +7.8% | |
| Q4 FY1995 | 0.13 | 0.14 | +7.69% | +27.27% | — | 504.30M | — | +16.12% | +4.8% | |
| Q3 FY1995 | 0.13 | 0.13 | 0.00% | +30.00% | — | 484.40M | — | +15.72% | -8.4% | |
| Q2 FY1995 | 0.12 | 0.12 | 0.00% | +20.00% | — | 484.10M | — | +18.83% | +1.9% | |
| Q1 FY1995 | 0.10 | 0.10 | 0.00% | +25.00% | — | 431.00M | — | +19.82% | +1.1% | |
| Q4 FY1994 | 0.11 | 0.11 | 0.00% | +37.50% | — | 434.30M | — | +20.71% | -0.3% | |
| Q3 FY1994 | 0.10 | 0.10 | 0.00% | +25.00% | — | 418.60M | — | +19.74% | +7.6% | |
| Q2 FY1994 | 0.09 | 0.10 | +11.11% | +25.00% | — | 407.40M | — | +20.11% | +4.6% | |
| Q1 FY1994 | 0.08 | 0.08 | 0.00% | +14.29% | — | 359.70M | — | +17.40% | +12.7% | |
| Q4 FY1993 | 0.08 | 0.08 | 0.00% | -33.28% | — | 359.80M | — | +18.36% | -6.5% | |
| Q3 FY1993 | 0.08 | 0.08 | 0.00% | — | — | 349.60M | — | — | -1.4% | |
| Q2 FY1993 | 0.07 | 0.08 | +14.29% | +14.29% | — | 339.20M | — | +31.68% | 0.0% | |
| Q1 FY1993 | 0.07 | 0.07 | 0.00% | — | — | 306.40M | — | — | +1.2% | |
| Q4 FY1992 | 0.07 | 0.07 | 0.00% | +22.89% | — | 299.90M | — | +43.08% | -7.6% | |
| Q4 FY1992 | — | 0.12 | — | +110.50% | — | 304.00M | — | +45.04% | 0.0% | |
| Q2 FY1992 | — | 0.07 | — | — | — | 257.60M | — | +68.59% | +0.3% | |
| Q4 FY1991 | — | 0.06 | — | — | — | 218.80M | — | +139.91% | -0.4% | |
| Q4 FY1991 | — | 0.06 | — | — | — | 209.60M | — | +129.82% | -1.4% | |
| Q3 FY1991 | — | 0.05 | — | +150.00% | — | 177.90M | — | +125.76% | +1.3% | |
| Q2 FY1991 | — | -0.05 | — | -485.51% | — | 152.80M | — | +113.11% | -0.8% | |
| Q4 FY1990 | — | 0.04 | — | +280.20% | — | 139.50M | — | +113.63% | -2.0% | |
| Q4 FY1990 | — | -0.03 | — | -400.00% | — | 91.20M | — | +39.66% | +2.7% | |
| Q3 FY1990 | — | 0.02 | — | +321.94% | — | 78.80M | — | +98.99% | +4.3% | |
| Q2 FY1990 | — | 0.01 | — | +1,223.47% | — | 71.70M | — | +152.46% | 0.0% | |
| Q4 FY1989 | — | 0.01 | — | — | — | 57.00M | — | +367.21% | 0.0% | |
| Q4 FY1989 | — | 0.01 | — | — | — | 65.30M | — | +435.25% | +4.9% | |
| Q3 FY1989 | — | 0.00 | — | — | — | 39.60M | — | — | +1.2% | |
| Q2 FY1989 | — | 0.00 | — | — | — | 28.40M | — | — | 0.0% | |
| Q4 FY1988 | — | -0.02 | — | -4,544.44% | — | 12.20M | — | -72.46% | +2.4% | |
| Q4 FY1987 | — | 0.00 | — | +114.29% | — | 44.30M | — | +48.66% | -3.9% | |
| Q4 FY1987 | — | 0.00 | — | +114.29% | — | 44.30M | — | +48.66% | -3.9% | |
| Q4 FY1987 | — | 0.00 | — | +114.29% | — | 44.30M | — | +48.66% | -3.9% | |
| Q4 FY1987 | — | 0.00 | — | +114.29% | — | 44.30M | — | +48.66% | -3.9% | |
| Q4 FY1986 | — | 0.00 | — | +61.54% | — | 29.80M | — | +41.23% | -0.6% | |
| Q4 FY1986 | — | 0.00 | — | +61.54% | — | 29.80M | — | +41.23% | -0.6% | |
| Q4 FY1986 | — | 0.00 | — | +61.54% | — | 29.80M | — | +41.23% | -0.6% | |
| Q4 FY1986 | — | 0.00 | — | +61.54% | — | 29.80M | — | +41.23% | -0.6% | |
| Q4 FY1985 | — | 0.00 | — | — | — | 21.10M | — | — | +2.1% | |
| Q4 FY1985 | — | 0.00 | — | — | — | 21.10M | — | — | +2.1% | |
| Q4 FY1985 | — | 0.00 | — | — | — | 21.10M | — | — | +2.1% | |
| Q4 FY1985 | — | 0.00 | — | — | — | 21.10M | — | — | +2.1% | |
| Q3 FY1985 | — | 0.01 | — | — | — | 7.50M | — | — | +1.5% |
| Period | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|
| FY2028 | 26.85 | — | — | +7.26% | 43.25B | — | — | +4.75% |
| FY2027 | 25.03 | — | — | +6.32% | 41.29B | — | — | +4.65% |
| FY2026 | 23.55 | — | — | +7.76% | 39.46B | — | — | +7.39% |
| FY2025 | 21.32 | 21.85 | +2.50% | +10.24% | 36.36B | 36.74B | +1.05% | +9.92% |
| FY2024 | 19.61 | 19.82 | +1.09% | +6.27% | 33.20B | 33.42B | +0.68% | +18.57% |
| FY2023 | 18.56 | 18.65 | +0.50% | +5.43% | 28.12B | 28.19B | +0.26% | +7.09% |
| FY2022 | 17.68 | 17.69 | +0.05% | +3.39% | 26.17B | 26.32B | +0.58% | +1.32% |
The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.
From the last earnings call, the company's guidance and analysts' previews, and checked against the report when it comes.
The outlook will show whether growth from newer medicines can offset declining sales of older drugs.
On average, analysts' EPS estimate was 8.6% off the result, either way, and their revenue estimate 2.4%, over the last 12 quarters.
See also:Forecast,EPS,Income statement
Source: Financial Modeling PrepVerified against SEC filings
We value your privacy
We use cookies to enhance your experience and analyze site traffic. By continuing, you agree to our use of cookies. Privacy Policy
